Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Immunotoxicity

Currently viewing:

Administrative data

Endpoint:
immunotoxicity
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given

Data source

Reference
Title:
No information
Author:
Li Q, Minami M, Inagaki H (1998) Acute snd subchronic|immunotoxicity of p-chloronitrobenzene in mice.I. Effect on|natural killer, cytotoxic T-lymphocyte activities and|mitogen-stimulated lymphocyte proliferation. Toxicology 127:|223-232

Materials and methods

Principles of method if other than guideline:
other: see remark
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Automatically generated during migration to IUCLID 6, no data available
IUPAC Name:
Automatically generated during migration to IUCLID 6, no data available
Details on test material:
- Name of test material (as cited in study report): 1-chloro-4-nitrobenzene
- Analytical purity: no data

Test animals

Species:
mouse
Strain:
other: T23-48:BDF1
Sex:
male

Administration / exposure

Route of administration:
other: i.p.
Vehicle:
other: olive oil
Frequency of treatment:
once
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 300 mg/kg bw/day
Basis:

No. of animals per sex per dose:
20
Control animals:
yes, concurrent vehicle
Details on study design:
Type: other
Observation period: up to 14 days

Results and discussion

Any other information on results incl. tables

Result: NK cell activity inhibited (3rd d>14th d), CTL activity weaker on d3  (returned to contr. level on d7), LPS-stimulated lymphocyte proliferation  weaker on d3, d7 (recovery up to d 14), no. of splenocytes increased, no  diff. in Hb conc. and bw

Applicant's summary and conclusion